Von Willebrand Faktör Eksikliğinde Sezaryen İçin Anestezi Yönetimi

Authors

Resul Yılmaz

Synopsis

Anesthesia management for a 30-year-old pregnant patient diagnosed with Von Willebrand Disease (VWD) undergoing a cesarean section is presented. Preoperatively, the patient’s Von Willebrand Factor (VWF) level was measured at 21 IU/dL, and following a hematology consultation, 75 IU/kg of factor concentrate was administered intravenously to raise the VWF level above 100 IU/dL prior to general anesthesia. Induction was achieved using propofol and rocuronium, after which the patient was intubated and maintained with sevoflurane. A healthy infant was delivered with intraoperative bleeding estimated at 450 mL. Postoperatively, the patient received three factor concentrate replacements of 35 IU/kg every 24 hours, leading to an uneventful recovery and discharge on the seventh postoperative day. VWD is the most common inherited bleeding disorder, affecting roughly 1% of the population, and carries a significant risk of peripartum hemorrhage despite physiological increases in clotting factors during pregnancy. Neuraxial anesthesia remains controversial, particularly in Type 3 cases due to spinal hematoma risks. Perioperative replacement therapy should maintain VWF levels between 50–100 IU/dL, requiring multidisciplinary care involving anesthesiologists, hematologists, and obstetricians.

References

Gezer S. Kanama diyatezi olan hastaya yaklaşım. HematoLog 2012; 2(2):1-7.

Hostetter RB, Mattei P, Schwartzentruber DJ. Surgery in specific hematologic conditions. In: Clinical Hematology. Mosby Elsevier, 2006.

Castaman G, Federici AB, Rodeghiero F, et al. Von Willebrand's disease in the year 2003: towards the complete identifi­cation of gene defects for correct diagnosis and treatment. Haematologica. 2003; 88(1): 94-108.

Castaman G, Goodeve A, Eikenboom J, on behalf of the European Group on von Willebrand disease (EUVWH). Principles of care for the diagnosis and treatment of von Willebrand disease. Haematologica 2013; 98(5): 667–74.

Battle J, Noya MS, Giangrande P et al. Advances in the therapy of von Willebrand disease. Haemop-hilia 2002; (8): 301-307.

Lee Ca, Kadir Ra, Kouides Pa. Inherited Bleeding Disorders İn Women. Wiley-Blackwell, Oxford, 2009.

Tosetto A, Rodeghiero F, Castaman G, et al. A Quantitative Analysis Of Bleeding Symptoms İn Type 1 Von Willebrand Disease: Results From A Multicenter European Study (Mcmdm-1 VWH). J Thromb Haemost 2006; 4(4): 766–73.

Lak M, Peyvandi F, Mannucci PM. Clinical Manifestations And Complications Of Childbirth And Replacement Therapy İn 385 Iranian Patients With Type 3 Von Willebrand Disease. Br J Haematol 2000; 111(4): 1236–9.

James AH, Jamison MG. Bleeding Events And Other Complications During Pregnancy And Childbirth İn Women With Von Willebrand Disease. J Thromb Haemost 2007; 5(6): 1165–9.

Siboni Sm, Spreafico M, Calò L, et al. Gynaecological And Obstetrical Problems İn Women With Different Bleeding Disorders. Haemophilia 2009; 15(6): 1291–9.

Castaman G, James Pd. Pregnancy And Delivery In Women With Von Willebrand Disease. Eur J Haematol. 2019; 103(2): 73–79. Doi:10.1111/Ejh.13250.

Mannucci PM. Treatment of von Willebrand's Disease. N Engl J Med 2004; 351(7): 683-694.

Castaman G, Federici AB, Rodeghiero F, et al. von Willebrand's disease in the year 2003: towards the complete identifi­cation of gene defects for correct diagnosis and treatment. Haematologica. 2003; 88(1): 94-108.

Federici AB, Mazurier C, Berntorp E, et al. Biologic re­sponse to desmopressin in patients with se­vere type 1 and type 2 von Willebrand disease: results of a multicenter European study. Blood. 2004; 103(6): 2032-8.

Sadler JE, Budde U, Eikenboom JC, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcom­mittee on von Willebrand Factor. Journal of Thrombosis and Haemostasis: JTH. 2006; 4(10): 2103-14.

Chee YL, Crawford JC, Watson HG, et al. Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematol­ogy. British Journal of Haematology. 2008; 140(5): 496-504.

Eckman MH, Erban JK, Singh SK, et al. Screening for the risk for bleeding or throm­bosis. Annals of Internal Medicine. 2003; 138(3): 15-24.

Mannucci PM, Franchini M, Castaman G, et al. Italian Association of Hemophilia Centers. Evidence-based recommendations on the treatment of von Willebrand disease in Italy. Blood Transfus 2009;7(2):117-26.

Thornton P, Douglas J. Coagulation in pregnancy. Best Pract Res Clin Obstet Gynaecol 2010; 24(3): 339-352.

Kadir RA, Lee CA, Sabin CA, et al. Pregnancy in women with von Willebrand’s disease or factor XI deficiency. Br J Obstet Gynaecol 1998; 105(3): 314–21.

Lavin M, Aguila S, Dalton N, et al. Significant gynecological bleeding in women with low von Willebrand factor. Blood Adv 2018; 2(14);1784–1791.

Castaman G, Tosetto A, Rodeghiero F. Shortened von Willebrand Factor survival: pathophysiologic and clinical relevance. J Thromb Haemost 2009; 7 (Suppl 1): 71–4.

Castaman G, Tosetto A, Rodeghiero F. Pregnancy and delivery in women with von Willebrand’s disease and different von Willebrand factor mutations. Haematologica 2010; 95(6): 963–9.

Cavallaro F, Sandroni C, Marano C, et al. Diagnostic accuracy of passive leg raising for prediction of fluid responsiveness in adults: Systematic review and meta-analysis of clinical studies. Intensive Care Med 2010;36(9):1475-83.

Yosunkaya A, Gök F. Yoğun Bakımda Hemodinamik Monitörizasyon. Türkiye klinikleri J Anest Reanim-Special Topics 2012;5(1):1-13.

Choi S, Brull R. Neuraxial techniques in obstetric and nonobstetric patients with common bleeding diatheses. Anesth Analg. 2009;109(2):648–660.

Lipe BC, Dumas MA, Ornstein DL. Von Willebrand disease in pregnancy. Hematol Oncol Clin North Am. 2011;25(2):335–358.

Committee on Adolescent Health Care; Committee on Gynecologic Practice. Committee opinion No.580: von Willebrand disease in women. Obstet Gynecol. 2013;122(6):1368–1373.

Chi C, Kadir RA. Inherited bleeding disorders in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2012;26(1):103–117.

Reynen E, James P. Von Willebrand disease and pregnancy: a review of evidence and expert opinion. Semin Thromb Hemost. 2016;42(7):717–723.

Parker JW, James PD, Haley SL. Spinal Anesthesia in 2 Consecutive Cesarean Deliveries in a Parturient With Type 3 von Willebrand Disease: A Case Report. A&A Practice. 2019;12(3):79–81.

Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWH): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14(2):171–232.

Castillo R, Monteagudo J, Escolar G, et al. Hemostatic effect of normal platelet transfusion in severe von Willebrand disease patients. Blood 1991;77(9):1901-5.

Allain JP. Non Factor VIII related constituents in concentrates. Scand J Haematol Suppl 1984;41:173-80.

Perkins HA. Correction of the hemostatic defects in von Willebrand's disease. Blood 1967;30(3):375-80.

Mannucci PM. Hemostatic Drugs. N Engl J Med 1998;339(4):245-53.

Yılmaz R, Yusifov M, Hacıbeyoglu G, et al. Comparison Of Preoperative Platelet Functions By Thromboelastogram İn Patients Selective Serotonin Re-Uptake İnhibitors User And Non-User. Ulus Travma Acil Cerrahi Derg. Ahead Of Print: Utd-96892 | Doı: 10.14744/Tjtes.2020.96892

TARD. Anestezi Uygulama Kılavuzları. Postanestezik Bakım. Türk Anesteziyoloji ve Reanimasyon Derneği, 2005.

Goldhill DR. Preventing surgical deaths:critical care and intensive care outreach services in the postoperative period. Br J Anesthesia. 2005; 95(1): 88-94.

Morgan EG. Care of the postanesthesia patients. In: Clinical Anesthesiology. 4th ed. New York: The McGrawHiII Companies; 2006.

Freeley TW, Macario A. Postanesthesia care unit. Miller RD, eds. Miller’s Anaesthesia. 6th ed. Philadelphia: Churchill Livingstone; 2005.

Vimlati L, Gilsanz, F, Goldik Z. Quality and safety guidelines of postanaesthesia care: Working Party on Post Anesthesia Care. Eur J Anaesthesiol. 2009; 26(9): 715-721.

Zdziarska J, Chojnowski K, Klukowska A, et al. Postępowanie w chorobie von Willebranda. Zalecenia Polskiego Towarzystwa Hematologów i Transfuzjologów 2008. Williams Obsterics, 25 th Edition. Wyd. McGraw-Hill Education/Medical 2018.

Windyga J, Stefańska-Windyga E, Baran B. Problemy położniczo-ginekologiczne w chorobie von Willebranda. Journal of Transfusion Medicine 2012;5(3):95-102.

Chee YL, Townend J, Crowther M, et al. Assessment of von Willebrand disease as a risk factor for primary postpartum haemorrhage. Haemophilia 2012;18(4):593–597.

Barnaś E, Skręt-MagierłoJ, Starzak-Gwóźdź J, et al. Hemorrhagic complications in a patient with von Willebrand disease. GinPolMedProject 2019;1(51):25-30.

James AH, Kouides PA, Abdul-Kadir R, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol. 2009;201(1):12.e1–12.e8.

Demers C, Derzko C, David M, et al. Gynaecological and obstetric management of women with inherited bleeding disorders. J Obstet Gynaecol Can. 2018;40(2):e91-e103

Published

January 13, 2022

License

License